| Bioactivity | ZLIRTLHEWY is a potent peptide CD47/SIRPα interaction inhibitor. ZLIRTLHEWY is promising for research of cancers[1]. |
| Sequence | {Pyr}-Leu-Ile-Arg-Thr-Leu-His-Glu-Trp-Tyr |
| Shortening | {Pyr}-LIRTLHEWY |
| Formula | C64H92N16O16 |
| Molar Mass | 1341.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zheng S, et al. Biomimetic Design of Peptide Inhibitor to Block CD47/SIRPα Interactions. Langmuir. 2023 Dec 12;39(49):18101-18112. |